Accutane Legislation Planned; Rep. Stupak Wants Mandatory Registries
This article was originally published in The Pink Sheet Daily
Executive Summary
The registry would require participation of all patients, prescribers, and dispensers of isotretinoin. Stupak calls into question the ability of Roche and FDA to manage such a registry.
You may also be interested in...
Allergan Tazoral PACT Program Will Register, Certify Physicians/Pharmacies
Mandatory pregnancy prevention registry will issue ID numbers upon physician/pharmacist certification and patient qualification. Tazarotene efficacy shown in moderate to severe psoriasis, but not in very severe disease, FDA says. Agency expresses concern about off-label use in acne.
Allergan Tazoral PACT Program Will Register, Certify Physicians/Pharmacies
Mandatory pregnancy prevention registry will issue ID numbers upon physician/pharmacist certification and patient qualification. Tazarotene efficacy shown in moderate to severe psoriasis, but not in very severe disease, FDA says. Agency expresses concern about off-label use in acne.
Accutane Prescriptions Would Be Limited To Approved Indication Under House Bill
Legislation from Reps. Stupak and Smith calls for mandatory registry for all Accutane users, prescribers and dispensers. The bill is based upon Roche's latest proposed risk management plan but adds some consumer protection provisions, such as an informed consent requirement for all patients.